Dermapharm Holding SE (ETR:DMP)
34.65
+0.40 (1.17%)
Aug 27, 2025, 5:35 PM CET
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2014 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2014 - 2019 |
Branded Medicine | 585.06M | Log In | Log In | Log In | Log In | Upgrade |
Branded Medicine Growth | 9.80% | Log In | Log In | Log In | Log In | Upgrade |
Other Health Products | 354.37M | Log In | Log In | Log In | Log In | Upgrade |
Other Health Products Growth | -4.66% | Log In | Log In | Log In | Log In | Upgrade |
Parallel Import | 241.34M | Log In | Log In | Log In | Log In | Upgrade |
Parallel Import Growth | 4.56% | Log In | Log In | Log In | Log In | Upgrade |
Branded Pharmaceuticals and Other Healthcare Products | - | Log In | Log In | Log In | Log In | Upgrade |
Branded Pharmaceuticals and Other Healthcare Products Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Herbal Extracts | - | Log In | Log In | Log In | Log In | Upgrade |
Herbal Extracts Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2014 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2014 - 2019 |
Germany | 725.56M | Log In | Log In | Log In | Log In | Upgrade |
Germany Growth | 2.63% | Log In | Log In | Log In | Log In | Upgrade |
France | 139.10M | Log In | Log In | Log In | Log In | Upgrade |
France Growth | -8.27% | Log In | Log In | Log In | Log In | Upgrade |
Spain | 117.57M | Log In | Log In | Log In | Log In | Upgrade |
Spain Growth | -0.73% | Log In | Log In | Log In | Log In | Upgrade |
Austria / Switzerland | 94.86M | Log In | Log In | Log In | Log In | Upgrade |
Austria / Switzerland Growth | 38.34% | Log In | Log In | Log In | Log In | Upgrade |
Other | 103.68M | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | 15.52% | Log In | Log In | Log In | Log In | Upgrade |